Delivery Order SPE2DB20D3103-SPE2DB23FM7N0
- Not listed
- The Defense Logistics Agency awarded a $103,700 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1 gram of gemcitabine in 26.3 milliliter vials. The single delivery order is to be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 26, 2023 to fulfill the Defense Logistics Agency's requirements for this chemotherapy drug. No additional details were provided regarding the context or purpose of the procurement, subcontractors, or designation...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price of $1,987.43 and a period of performance through June 16, 2025. The contract is not set aside and was awarded on June 15, 2025. AmerisourceBergen Drug Corp holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of various pharmaceutical and medical products. The contract, valued at $1,168.50, is a firm fixed-price delivery order without a set-aside designation, indicating open competition. The products being delivered include medications across multiple therapeutic areas such as diabetes, neurology, pain management, and specialty pharmaceuticals....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,597.28 firm-fixed-price contract is for the delivery of pharmaceutical products and medical supplies to support military and federal healthcare programs. The contract has a performance period through May 2025 and is not set aside for any special business category. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $203,058.18 firm-fixed-price contract is for the delivery of various pharmaceutical products and medical supplies, including prescription medications, medical devices, specialty pharmaceuticals, vaccines, and other healthcare-related items. The contract supports DLA's medical supply chain operations and is not set aside for a particular...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,223.59 firm fixed-price contract is for the provision of various medical products, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has an ultimate completion date of April 9, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the provision of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has a ceiling value of $2,006.70 and a completion date of February 10, 2021. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,213.44, is a firm fixed-price delivery order with a completion date of May 8, 2025. The contract is not set aside and allows for the delivery of a variety of pharmaceutical products and medical supplies to support federal medical procurement needs, particularly for military and veteran...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,707.47, is for the supply of a range of pharmaceutical products and medical supplies to support military healthcare programs. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,492.76, is a firm-fixed-price delivery order with an ultimate completion date of April 29, 2025. The contract provides for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FM7N0Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Gemcitabine HCL 2 gram vials. The contract, valued at $1,052.20, is a firm fixed-price delivery order contract with a completion date of March 15, 2023. The contract does not have any set-aside designations, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is part of the larger IDC that enables the DLA to efficiently procure essential medications and medical commodities to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 3/14/23 |